With schools returning to 100% in-person learning this month, some doctors said the results of a statewide antibody study show why masks are still necessary. STORY:
A new study on antibody production shows people who experienced mild illness from COVID-19, developed long-lasting antibody protection.
In a major development, Oxford’s Covid vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose followed by a half-dose booster. Watch full bulletin. #OxfordCovidVaccine #CovidVaccine #Coronavirus #IndiaToday Subscribe to India Today…
2 Doses of Oxford Coronavirus Vaccine Provoked Good Immune Response, Data Shows #LatestNews #EtvAndhraPradesh
Hospitalized Covid-19 patients share vitamin D deficiency, research shows
In this video we will dive into an interesting study that used a Golden Hamster model to test the efficacy of Ivermectin in COVID-19. They inoculated or gave these hamsters SARS-CoV-2 virus and then treated half with intramuscular Ivermectin and…
